Importantly, statistical analysis showed that ovarian cancer patients with high FAM46A expression had significantly worse overall and disease-free survival than those with low FAM46A expression (Figure 1(g) and Supplementary Table 3–4). This evidence concerns the gene TENT5A and ovarian carcinoma.